APA (7th ed.) Citation

Tingfei Tan, Gongwei Han, Ziwei Cheng, Jiemei Jiang, Li Zhang, Zitong Xia, . . . Quan Xia. (2022). Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Tingfei Tan, Gongwei Han, Ziwei Cheng, Jiemei Jiang, Li Zhang, Zitong Xia, Xinmeng Wang, and Quan Xia. Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Tingfei Tan, et al. Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer. Frontiers Media S.A., 2022.